Discover why Hims & Hers is leading the telehealth market with strong growth, a loyal user base, and expansion into new ...

The two products accounted for about 48% of Eli Lilly's most recent quarterly sales and drove most of the top-line growth.

The feud heats up as Gov. Landry unofficially calls for a special session to rein in rising prescription drug costs and take ...

Calling it a “difficult decision,” Gov. Kim Reynolds signed legislation Wednesday that’s intended to help keep rural pharmacies in business but could also lead to higher drug costs for Iowans.

Gov. Jeff Landry is threatening to call a special session to try to pass the tougher bill, which CVS says could force it to ...

A closely watched bill that aimed to regulate pharmacy benefit managers, or PBMs, failed to make it through the Senate. But ...

Like a solar flare suddenly erupting, in the last week of its session after little attention to the issue the Louisiana Legislature appears poised to enact significant and almost unprecedented ...

As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how ...

Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchers ...

UroGen Pharma's FDA nod for UGN-102 fuels recovery, but cash burn raises financing risks. Check out why I am maintaining my ...

Sanofi (NASDAQ: SNY) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Berenberg Bank analyst Luisa Hector ...